España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Bristol-myers Squibb
Benzinga's Bulls And Bears Of The Week: Amazon, Apple, Bitcoin, GameStop, Netflix And More
Benzinga's Bulls And Bears Of The Week: Apple, GM, JetBlue, Lululemon, Tesla And More
Barron's Latest Picks And Pans: Apple, Coupang, GameStop, Uber, Walker & Dunlop And More
Benzinga's Bulls And Bears Of The Week: Apple, GM, JetBlue, Lululemon, Tesla And More
Barron's Latest Picks And Pans: Apple, Coupang, GameStop, Uber, Walker & Dunlop And More
Benzinga's Bulls And Bears Of The Week: Amazon, Disney, Netflix And More
Notable Insider Buys: AbbVie, Bristol-Myers And More
Benzinga's Bulls And Bears Of The Week: Amazon, Disney, Netflix And More
Notable Insider Buys: AbbVie, Bristol-Myers And More
Bulls & Bears Of The Week: AT&T, Carnival, McDonald's, Microsoft And More
Benzinga's Bulls & Bears Of The Week: Dropbox, GE, Microsoft, Twitter And More
Read More...
Bristol-myers Squibb Recent News
Benzinga's Bulls & Bears Of The Week: Bristol-Myers, GE, Target, Under Armour And More
Ahead Of Earnings: Why You Should Be Buying Merck And Selling Bristol-Myers
Barron's Picks And Pans: Bristol-Myers, Texas Instruments, Altaba And More
Short Sellers Pile On Pfizer After Buyout Rumors
Biotech In The Earnings Spotlight: Amgen, Celgene, Gilead Sciences
Big Biotech In The Earnings Spotlight
Barron's: Are Trump And Sanders Killing The Market?
Barron's Picks And Pans: Bristol-Myers Squibb, KeyCorp, Core-Mark And More
Credit Suisse: We Prefer Pfizer, Bristol Over Pharma Peers
With Bristol-Myers Trial Stopped Early, 'What's Next?'
Bristol-Myers Up Big After Drug Study Stopped Early
Bristol-Myers Squibb Is Re-Testing Its Breakout Level
5 Companies That Could Develop An Enterovirus Treatment
Markets Little Changed In Low Volume And Slow News Ahead Of Long Weekend
Markets Marginally Higher On Light Volume And Encouraging Geopolitical Developments
Dow Sets New Intraday High; Citigroup Impresses With Earnings
Earnings Expectations For The Week Of April 28: Big Oil, Big Pharma And More
Market Wrap For February 25: Markets End The Day Relatively Flat
Earnings Expectations For The Week Of January 20: Microsoft, McDonald's, Netflix And More
Market Wrap For December 20: Markets Gain On GDP Data
Market Wrap For December 18: Markets Flat During Day One Post Fed Taper
Earnings Expectations For The Week Of October 21: The Crunch Is On
Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)